Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FRACTALKINE GENE RECEPTOR POLYMORPHISM IN PATIENTS WITH MULTIPLE SCLEROSIS.
Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis.
Neuromyelitis optica in a child with Aicardi-Goutières syndrome.
Imaging resting state brain function in multiple sclerosis.
Transverse myelitis following combined spinal-epidural anesthesia.
Missing links in multiple sclerosis etiology. A working connecting hypothesis.
Gait variability and multiple sclerosis.
Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23.
[Ophthalmological Findings in Paediatric and Adolescent Multiple Sclerosis.]
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review.
Analysis of prognostic factors associated with longitudinally extensive transverse myelitis.
Symptomatic Sinus Bradycardia After a Treatment Course Of High-dose Oral Prednisone.
Early onset (childhood) monogenic neuropathies.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
[Neuropathology of multiple sclerosis].
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data.
Vitamin D insufficiency and chronic diseases: Hype and reality.

Pages